| ApoE genotype accounts for the vast majority of AD risk and AD pathology J Raber, Y Huang, JW Ashford Neurobiology of aging 25 (5), 641-650, 2004 | 792 | 2004 |
| “Preclinical” AD revisited: neuropathology of cognitively normal older adults FA Schmitt, DG Davis, DR Wekstein, CD Smith, JW Ashford, ... Neurology 55 (3), 370-376, 2000 | 461 | 2000 |
| Severe family violence and Alzheimer's disease: prevalence and risk factors GJ Paveza, D Cohen, C Eisdorfer, S Freels, T Semla, JW Ashford, ... The Gerontologist 32 (4), 493-497, 1992 | 416 | 1992 |
| APOE genotype effects on alzheimer’s disease onset and epidemiology JW Ashford Journal of Molecular Neuroscience 23, 157-165, 2004 | 323 | 2004 |
| Improving dementia care: the role of screening and detection of cognitive impairment S Borson, L Frank, PJ Bayley, M Boustani, M Dean, PJ Lin, JR McCarten, ... Alzheimer's & Dementia 9 (2), 151-159, 2013 | 316 | 2013 |
| Leptin reduces pathology and improves memory in a transgenic mouse model of Alzheimer's disease SJ Greco, KJ Bryan, S Sarkar, X Zhu, MA Smith, JW Ashford, JM Johnston, ... Journal of Alzheimer's Disease 19 (4), 1155-1167, 2010 | 267 | 2010 |
| Ascending monoaminergic systems alterations in Alzheimer's disease. Translating basic science into clinical care L Trillo, D Das, W Hsieh, B Medina, S Moghadam, B Lin, V Dang, ... Neuroscience & Biobehavioral Reviews 37 (8), 1363-1379, 2013 | 256 | 2013 |
| Age, education, and changes in the Mini‐Mental State Exam scores of older women: Findings from the Nun Study SM Butler, JW Ashford, DA Snowdon Journal of the American Geriatrics Society 44 (6), 675-681, 1996 | 253 | 1996 |
| Non-familial Alzheimer's disease is mainly due to genetic factors JW Ashford, JA Mortimer Journal of Alzheimer's disease 4 (3), 169-177, 2002 | 201 | 2002 |
| Modelling mini mental state examination changes in Alzheimer's disease MS Mendiondo, JW Ashford, RJ Kryscio, FA Schmitt Statistics in medicine 19 (11‐12), 1607-1616, 2000 | 192 | 2000 |
| Alzheimer patient evaluation and the mini-mental state: item characteristic curve analysis JW Ashford, P Kolm, JA Colliver, C Bekian, LN Hsu Journal of Gerontology 44 (5), P139-P146, 1989 | 188 | 1989 |
| Neuropsychiatric diagnosis and management of chronic sequelae of war-related mild to moderate traumatic brain injury JD Halbauer, JW Ashford, HL Lew, JA Yesavage Journal of rehabilitation research and development 46 (6), 757, 2009 | 183 | 2009 |
| An empirical evaluation of the Global Deterioration Scale for staging Alzheimer’s disease J Wesson, J Luchins Am. J. Psychiatry 149, 190-194, 1992 | 174 | 1992 |
| Leptin reduces Alzheimer’s disease-related tau phosphorylation in neuronal cells SJ Greco, S Sarkar, JM Johnston, X Zhu, B Su, G Casadesus, JW Ashford, ... Biochemical and biophysical research communications 376 (3), 536-541, 2008 | 164 | 2008 |
| Neuroplasticity in Alzheimer's disease B Teter, JW Ashford Journal of neuroscience research 70 (3), 402-437, 2002 | 161 | 2002 |
| Leptin: a novel therapeutic strategy for Alzheimer's disease N Tezapsidis, JM Johnston, MA Smith, JW Ashford, G Casadesus, ... Journal of Alzheimer's Disease 16 (4), 731-740, 2009 | 158 | 2009 |
| Leptin inhibits glycogen synthase kinase-3β to prevent tau phosphorylation in neuronal cells SJ Greco, S Sarkar, G Casadesus, X Zhu, MA Smith, JW Ashford, ... Neuroscience letters 455 (3), 191-194, 2009 | 148 | 2009 |
| Anticonvulsants attenuate amyloid β-peptide neurotoxicity, Ca2+ deregulation, and cytoskeletal pathology RJ Mark, JW Ashford, Y Goodman, MP Mattson Neurobiology of aging 16 (2), 187-198, 1995 | 135 | 1995 |
| Comparison of neuropathologic criteria for the diagnosis of Alzheimer’s disease JW Geddes, TL Tekirian, NS Soultanian, JW Ashford, DG Davis, ... Neurobiology of aging 18 (4), S99-S105, 1997 | 131 | 1997 |
| Psychopathology associated with Alzheimer's disease and related disorders D Cohen, C Eisdorfer, P Gorelick, G Paveza, DJ Luchins, S Freels, ... Journal of Gerontology 48 (6), M255-M260, 1993 | 130 | 1993 |
